Pages that link to "Q60777482"

The following pages link to Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis (Q60777482):

Displaying 35 items.

• Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma (Q28206821) (← links)
• Applications of transgenics in studies of bone sialoprotein (Q33677504) (← links)
• Antitumour effects of bisphosphonates: first evidence and possible mechanisms (Q33897197) (← links)
• Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG). (Q33898576) (← links)
• Expression of bone sialoprotein and osteopontin in breast cancer bone metastases (Q33943539) (← links)
• Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis (Q34221672) (← links)
• Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases (Q34325491) (← links)
• The role of bisphosphonates as adjuvant therapy for breast cancer (Q34397795) (← links)
• High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients (Q34465050) (← links)
• Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer (Q34655823) (← links)
• Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer (Q34909724) (← links)
• Bone remodeling markers and bone metastases: From cancer research to clinical implications (Q35531006) (← links)
• The role of the bone microenvironment in skeletal metastasis. (Q36491430) (← links)
• Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation (Q36612227) (← links)
• Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. (Q36622607) (← links)
• BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells (Q36824242) (← links)
• Matricellular proteins as regulators of cancer metastasis to bone (Q36923653) (← links)
• Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells (Q37152195) (← links)
• Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice (Q37200578) (← links)
• Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer (Q37402732) (← links)
• Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers (Q37625382) (← links)
• Bone metastasis risk factors in breast cancer. (Q37629662) (← links)
• A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events. (Q37656386) (← links)
• A Molecular View of Pathological Microcalcification in Breast Cancer (Q38697305) (← links)
• Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231(GFP) breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude rats (Q40106076) (← links)
• Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice (Q40569932) (← links)
• Predictive value of serum bone sialoprotein and prostate-specific antigen doubling time in patients with bone metastasis of prostate cancer (Q43462306) (← links)
• IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis (Q49613885) (← links)
• Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions. (Q53646030) (← links)
• Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer (Q58795240) (← links)
• Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis (Q60777451) (← links)
• Bone Sialoprotein Shows Enhanced Expression in Early, High-Proliferation Stages of Three-Dimensional Spheroid Cell Cultures of Breast Cancer Cell Line MDA-MB-231 (Q64236083) (← links)
• [Clinical relevance of biomarkers in cancer related bone disease] (Q81408333) (← links)
• Alteration of bone sialoprotein expression in osseous metastasized renal cell carcinomas and the tumor surrounding tissue (Q82751489) (← links)
• Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone (Q92740985) (← links)